NLS Pharmaceutics Ltd (NLSP)
1.920
-0.46
(-19.33%)
USD |
NASDAQ |
Dec 20, 16:00
1.95
+0.03
(+1.57%)
After-Hours: 20:00
NLS Pharmaceutics Total Liabilities (Quarterly): 10.46M for June 30, 2024
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| AC Immune SA | 135.61M |
| CRISPR Therapeutics AG | 316.47M |
| Addex Therapeutics Ltd | 1.315M |
| Molecular Partners AG | 18.34M |
| MoonLake Immunotherapeutics | 22.71M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 1.194M |
| Shareholders Equity (Quarterly) | -9.268M |